Background/Aims: To identify the number and potential causes of unnecessary diagnostic procedures in a cohort of patients with autoimmune pancreatitis (AIP). Methods: All AIP cases at our centre between April 2006 and April 2013 were collected and followed up. Diagnosis was established by the International Consensus Diagnostic Criteria (ICDC). Demographic, clinical, radiological, serological data, the number of diagnostic procedures and the reason for referral were recorded. Possible risk factors for a delayed diagnosis of AIP were analysed. Results: A total of 29 patients (median age 60 years; 22 males and 7 females) were diagnosed with AIP using ICDC. Twenty-five patients were diagnosed with definite, 2 with possible type 1 AIP and 2 with type 2 AIP. In 29 patients, 50 ERCPs and 18 EUS were carried out; based on ICDC recommendations, a total of 20 ERCPs and 4 EUS were unnecessary diagnostic procedures. Eight patients (23.0%) were referred for unnecessary surgery. Jaundice was shown to be a significant risk factor for unnecessary endoscopic investigations (OR 11.00, 95% CI 1.14-106.43, p = 0.04). Conclusion: Diagnosis of AIP still remains a challenge. Patients with jaundice are at particular risk of being subjected to unnecessary endoscopic procedures. Use of ICDC would help avoid unnecessary examinations or even major surgeries at times.

1.
Stone JH, Zen Y, Deshpande V: IgG4-related disease. N Engl J Med 2012;366:539-551.
2.
Chari ST, Smyrk TC, Levy MJ, et al: Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006;4:1010-1016; quiz 934.
3.
Church NI, Pereira SP, Deheragoda MG, et al: Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 2007;102:2417-2425.
4.
Kamisawa T, Funata N, Hayashi Y, et al: Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003;52:683-687.
5.
Okazaki K, Kawa S, Kamisawa T, et al: Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol 2010;45:249-265.
6.
Kamisawa T, Chari ST, Giday SA, et al: Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas 2011;40:809-814.
7.
Pearson RK, Longnecker DS, Chari ST, et al: Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 2003;27:1-13.
8.
Detlefsen S, Drewes AM: Autoimmune pancreatitis. Scand J Gastroenterol 2009;44:1391-1407.
9.
Takahashi N, Fletcher JG, Fidler JL, et al: Dual-phase CT of autoimmune pancreatitis: a multireader study. AJR Am J Roentgenol 2008;190:280-286.
10.
Kamisawa T, Yoshiike M, Egawa N, et al: Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 2005;5:234-238; discussion 238-240.
11.
Sumimoto K, Uchida K, Mitsuyama T, et al: A proposal of a diagnostic algorithm with validation of international consensus diagnostic criteria for autoimmune pancreatitis in a Japanese cohort. Pancreatology 2013;13:230-237.
12.
Learn PA, Grossman EB, Do RK, et al: Pitfalls in avoiding operation for autoimmune pancreatitis. Surgery 2011;150:968-974.
13.
Sah RP, Pannala R, Chari ST, et al: Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol 2010;8:91-96.
14.
Maire F, Le Baleur Y, Rebours V, et al: Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol 2011;106:151-156.
15.
Zamboni G, Lüttges J, Capelli P, et al: Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004;445:552-563.
16.
Okazaki K, Uchida K, Koyabu M, et al: Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol 2011;46:277-288.
17.
Frulloni L, Scattolini C, Falconi M, et al: Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol 2009;104:2288-2294.
18.
Shimosegawa T, Chari ST, Frulloni L, et al: International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the international association of pancreatology. Pancreas 2011;40:352-358.
19.
Otsuki M, Chung JB, Okazaki K, et al: Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis. J Gastroenterol 2008;43:403-408.
20.
Schneider A, Löhr JM, Singer MV: The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol 2007;42:101-119.
21.
Kamisawa T, Okazaki K, Kawa S, et al: Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 2010;45:471-477.
22.
Kawa S, Okazaki K, Kamisawa T, et al: Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol 2010;45:355-369.
23.
Okazaki K, Kawa S, Kamisawa T, et al; Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society: Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol 2010;45:249-265.
24.
Chari ST, Takahashi N, Levy MJ, et al: A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 2009;7:1097-1103.
25.
Kamisawa T, Imai M, Yui Chen P, et al: Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas 2008;37:e62-e67.
26.
Agrawal S, Daruwala C, Khurana J: Distinguishing autoimmune pancreatitis from pancreaticobiliary cancers: current strategy. Ann Surg 2012;255:248-258.
27.
Kim KP, Kim MH, Song MH, et al: Autoimmune chronic pancreatitis. Am J Gastroenterol 2004;99:1605-1616.
You do not currently have access to this content.